Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Cingulate Therapeutics Partners with Camargo Pharmaceutical Services for Development Programs
Wednesday, August 09, 2017Cingulate Therapeutics LLC a clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit Hyperactivity Disorder ADHD today announced that it has entered into service agree...
La Jolla Pharmaceutical Company Announces Launch of Expanded Access Program for LJPC-501
Wednesday, August 09, 2017La Jolla Pharmaceutical Company today announced that the Company has initiated an expanded access program EAP in the United States to provide its investigational drug LJPC angiotensin II to patients with vasodilatory or distributive shock who cannot...
Charles River Laboratories Acquires Brains On-Line
Tuesday, August 08, 2017Charles River Laboratories International Inc announced that it has acquired Brains OnLine a leading contract research organization CRO providing critical data that advances novel therapeutics for the treatment of central nervous system CNS diseases W...
HitGen and LEO Pharma Enter Research Collaboration
Tuesday, August 08, 2017HitGen Ltd announced that the company has entered into a multitarget multiyear collaboration with LEO Pharma AS to discover novel small molecule leads for multiple therapeutic targets of interest to LEO Pharma According to the agreement HitGen will...
PeptiDream to set up Osaka-based special peptide drugs JV
Monday, August 07, 2017PeptiDream Inc Says it plans to set up Osakabased joint venture with Shionogi Co Ltd and Sekisui Chemical Co Ltd on Sept Says the joint venture will be engaged in RD production and sales of special peptide drugs
FDA Grants Orphan Drug Designation to Omeros’ OMS721 for Treatment of IgA Nephropathy
Monday, August 07, 2017Omeros Corporation announced that OMS has received orphan drug designation from the US Food and Drug Administration FDA for the treatment of Immunoglobulin A IgA nephropathy OMS is Omeros lead human monoclonal antibody targeting mannanbinding lectina...
Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin
Saturday, August 05, 2017Mallinckrodt plc a leading global specialty pharmaceutical company and InfaCare Pharmaceutical Corporation today announced that they have entered into an agreement under which Mallinckrodt will acquire InfaCare a privately held specialty pharmaceutic...
Nexus Pharmaceuticals Receives FDA Approval for Isoproterenol Hydrochloride Injection USP
Friday, August 04, 2017Nexus Pharmaceuticals announced that it has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Isoproterenol Hydrochloride Injection Nexus Pharmaceuticals Isoproterenol Hydrochloride Injec...
Bristol-Myers Squibb to Acquire IFM Therapeutics
Friday, August 04, 2017BristolMyers Squibb Company NYSEBMY and IFM Therapeutics IFM announced today that the companies have signed a definitive agreement under which BristolMyers Squibb will acquire all of the outstanding capital stock of IFM Therapeutics a venturebacked b...
Takeda and Molecular Templates Announce Multi-Target Research and Licensing Collaboration
Friday, August 04, 2017Takeda Pharmaceutical Company Limited and Molecular Templates Inc today announced a collaboration agreement for oncology drug discovery programs The collaboration will apply Molecular Templates engineered toxin bodies ETB technology platform to poten...
